![389 A phase I study evaluating the pharmacokinetics (PK) and pharmacodynamic (PD) activity of the dual PI3K/mTor inhibitor GDC-0980 administered QW]()
389 A phase I study evaluating the pharmacokinetics (PK) and pharmacodynamic (PD) activity of the dual PI3K/mTor inhibitor GDC-0980 administered QWA.J. Wagner; G.C. Jayson; C. Gomez-Roca; Y.K. Zee; J.A. Morgan; Y. Yan; J. Ware; K.E. Mazina; J. Lauchle; J.C. Soria · 2010